Invention Grant
US09383363B2 LASP-1, a novel urinary marker for transitional cell carcinoma detection
有权
LASP-1，一种用于移行细胞癌检测的新型尿标志物
- Patent Title: LASP-1, a novel urinary marker for transitional cell carcinoma detection
- Patent Title (中): LASP-1，一种用于移行细胞癌检测的新型尿标志物
-
Application No.: US14363064Application Date: 2012-12-06
-
Publication No.: US09383363B2Publication Date: 2016-07-05
- Inventor: Elke Butt
- Applicant: Elke Butt
- Applicant Address: DE Würzburg
- Assignee: Julius-Maximilians-Universität-Würzburg
- Current Assignee: Julius-Maximilians-Universität-Würzburg
- Current Assignee Address: DE Würzburg
- Agency: DT Ward, PC
- Agent Donna T. Ward; Lingyun Jia
- Priority: EP11009694 20111208
- International Application: PCT/EP2012/074634 WO 20121206
- International Announcement: WO2013/083690 WO 20130613
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/574 ; G01N33/493 ; A61B1/307 ; H01J49/26
Abstract:
The invention relates to the use of LASP-1 in a urine sample obtained from a subject for diagnosing and/or grading transitional cell carcinoma. The invention furthermore relates to a method for diagnosing transitional cell carcinoma comprising detecting the presence or absence of LASP-1 in a urine sample obtained from a subject, wherein the presence of LASP-1 above 1 ng/500 μl urine is indicative for transitional cell carcinoma and a method for grading transitional cell carcinoma comprising determining the level of LASP-1 in a urine sample obtained from a subject, wherein the level of LASP-1 correlates with the grade of the transitional cell carcinoma.
Public/Granted literature
- US20140370530A1 LASP-1, a novel Urinary Marker for Transitional Cell Carcinoma Detection Public/Granted day:2014-12-18
Information query
IPC分类:
